Genetics and Genomics of Coronary Artery Disease: What We Have Learned
Canadian Journal of Cardiology · 2026-05 · 42 (5) · S10-S21
DOI: 10.1016/j.cjca.2026.01.051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2026-05. Verfasst von Ruth McPherson. Beteiligte Einrichtung: Atherogenomics Laboratory, John & Jennifer Ruddy Canadian Cardiovascular Genetics Centre, Division of Cardiology, University of Ottawa Heart Institut…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Genomics, Genetic Predisposition to Disease. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Ottawa Heart Institute Foundation, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Research over the past 2 decades has provided a broader understanding of the genetic architecture of coronary artery disease (CAD) and shows that it derives in large part from the cumulative effect of multiple common risk alleles that are individually of small effect size but cumulatively have large effects on CAD risk. The tools applied include genome-wide association study (GWAS), which encompasses thousands of individuals, complemented by deep sequencing and extensive omic data sets. More than 300 genome-wide significant loci associated with CAD risk have been identified using the GWAS approach; 90% of these are situated in intergenic regions. Our research at the University of Ottawa Heart Institute has been carried out in collaboration with an extensive number of groups and individuals around the world. These studies include computational approaches to better understand missing heritability and identify causal pathways, experimental approaches to reveal, at the molecular level, the function of the multiple risk loci. In addition to providing new insight into the biology of atherosclerosis and its clinical sequelae, GWAS findings have important applications in clinical cardiovascular medicine. These include Mendelian randomization analyses to identify causal biomarkers and generation of polygenic risk scores to improve CAD risk prediction and guide decision-making regarding preventive therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Atherogenomics Laboratory, John & Jennifer Ruddy Canadian Cardiovascular Genetics Centre, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: rmcpherson@ottawaheart…
Förderung
- University of Ottawa Heart Institute Foundation
- Canadian Institutes of Health Research
Zitieren
APA
McPherson, R. (2026). Genetics and Genomics of Coronary Artery Disease: What We Have Learned. Canadian Journal of Cardiology, 42(5), S10-S21. https://doi.org/10.1016/j.cjca.2026.01.051
Vancouver
McPherson R. Genetics and Genomics of Coronary Artery Disease: What We Have Learned. Canadian Journal of Cardiology. 2026;42(5):S10-S21. doi:10.1016/j.cjca.2026.01.051
BibTeX
@article{McPherson2026,
author = {McPherson, Ruth},
title = {Genetics and Genomics of Coronary Artery Disease: What We Have Learned},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {5},
pages = {S10--S21},
doi = {10.1016/j.cjca.2026.01.051}
}
EUVIMED